NeoGenomics
253 hedge funds and large institutions have $1.93B invested in NeoGenomics in 2019 Q2 according to their latest regulatory filings, with 43 funds opening new positions, 112 increasing their positions, 67 reducing their positions, and 22 closing their positions.
328% more call options, than puts
Call options by funds: $6.74M | Put options by funds: $1.58M
95% more first-time investments, than exits
New positions opened: 43 | Existing positions closed: 22
67% more repeat investments, than reductions
Existing positions increased: 112 | Existing positions reduced: 67
17% more capital invested
Capital invested by funds: $1.65B → $1.93B (+$287M)
8% more funds holding
Funds holding: 235 → 253 (+18)
0.9% more ownership
Funds ownership: 85.15% → 86.05% (+0.9%)
0% more funds holding in top 10
Funds holding in top 10: 9 → 9 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$52.7M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$24.8M |
| 3 |
GT
Glenmede Trust
Philadelphia,
Pennsylvania
|
+$24.3M |
| 4 |
BlackRock
New York
|
+$24.1M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$20.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
|
-$24.3M |
| 2 |
ECM
Element Capital Management
New York
|
-$6.54M |
| 3 |
Bank of New York Mellon
New York
|
-$6.42M |
| 4 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$6.12M |
| 5 |
CPA
Cowen Prime Advisors
New York
|
-$4.03M |
NEO Hedge Fund Activity: Q2 2019 in Review
253 of the 4,625 institutional investors tracked by Wall St. Rank reported a position in NeoGenomics (NEO) for Q2 2019, worth a combined $1.93B — up 17% from $1.65B a quarter earlier.
Buyers outnumbered sellers: 43 funds opened new NEO positions and 22 closed out — a net gain of 21 holders — while 112 added to existing stakes and 67 trimmed.
The largest buyer was Vanguard Group, adding an estimated $52.7M. The largest seller was Janus Henderson Group, cutting an estimated $24.3M.
- 253 institutional investors held NeoGenomics (NEO) as of Q2 2019, up from 235 in Q1 2019.
- Funds reported $1.93B of NeoGenomics stock for Q2 2019, up 17% quarter-over-quarter.
- 43 funds opened new NeoGenomics positions in Q2 2019 and 22 closed out, a net change of +21 holders.
- The largest NeoGenomics buyer in Q2 2019 was Vanguard Group, an estimated $52.7M added.
- The largest NeoGenomics seller in Q2 2019 was Janus Henderson Group, an estimated $24.3M sold.
Based on aggregated 13F filings for Q2 2019.